Topchoice Medical Co., Inc. (SHA:600763)
China · Delayed Price · Currency is CNY 35.59
+1.38 (4.03%)
Oct 30, 2026, 3:00 PM CST
Topchoice Medical Co. Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 617.53 | 696.33 | 620.56 | 594.48 | 630.32 | 843.99 |
Trading Asset Securities | 2.32 | 2.32 | 1.42 | - | - | - |
Cash & Short-Term Investments | 619.84 | 698.64 | 621.98 | 594.48 | 630.32 | 843.99 |
Cash Growth | 7.15% | 12.33% | 4.63% | -5.69% | -25.32% | 25.20% |
Accounts Receivable | 149.92 | 169.3 | 151.03 | 137.51 | 104.95 | 73.51 |
Other Receivables | 200.95 | 84.13 | 74.88 | 64.4 | 59.7 | 55.49 |
Receivables | 350.87 | 253.43 | 225.91 | 321.91 | 424.65 | 129 |
Inventory | 39.12 | 19.77 | 29.99 | 24.8 | 22.9 | 20.34 |
Other Current Assets | 71.24 | 53.54 | 39.76 | 28.18 | 34.02 | 27.7 |
Total Current Assets | 1,081 | 1,025 | 917.64 | 969.37 | 1,112 | 1,021 |
Property, Plant & Equipment | 2,602 | 2,638 | 2,937 | 2,753 | 2,203 | 2,245 |
Long-Term Investments | 1,172 | 1,045 | 1,147 | 1,156 | 644.73 | 725.94 |
Goodwill | 73.06 | 73.06 | 73.06 | 50.28 | 50.28 | 50.28 |
Other Intangible Assets | 171.46 | 174.38 | 79.68 | 58.66 | 12.37 | 12.85 |
Long-Term Deferred Tax Assets | 101.47 | 101.13 | 61.5 | 22.08 | 12.5 | 4.96 |
Long-Term Deferred Charges | 417.96 | 424.91 | 389.84 | 376.84 | 334.45 | 244.28 |
Other Long-Term Assets | 630.82 | 62.06 | 156.64 | 256.22 | 421.26 | 82.76 |
Total Assets | 6,249 | 6,042 | 6,228 | 6,062 | 5,154 | 4,955 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 173.19 | 149.4 | 182.49 | 183.3 | 140.52 | 173.53 |
Accrued Expenses | 9.03 | 36.24 | 45.6 | 67.99 | 38.92 | 41.92 |
Short-Term Debt | 450.21 | 50.6 | 80.62 | 125.72 | 0.48 | 1.37 |
Current Portion of Long-Term Debt | 122.65 | 169.17 | 20.22 | 39.07 | 41.1 | 70.13 |
Current Portion of Leases | - | 153.69 | 109.23 | 100.67 | 99.82 | 96.32 |
Current Income Taxes Payable | 61.93 | 81.43 | 98.72 | 115.17 | 103.06 | 188.89 |
Current Unearned Revenue | 11.97 | 18.45 | 19.82 | 19.77 | 20.38 | 19.97 |
Other Current Liabilities | 28.84 | 31.2 | 36.45 | 39.3 | 33.18 | 32.77 |
Total Current Liabilities | 857.83 | 690.18 | 593.15 | 690.99 | 477.46 | 624.89 |
Long-Term Debt | - | - | 169 | 189 | 28.8 | 109.96 |
Long-Term Leases | 661.79 | 738.75 | 1,065 | 1,005 | 983.75 | 1,021 |
Long-Term Unearned Revenue | 11.93 | 12.94 | 14.38 | 16.11 | 17.6 | 19.24 |
Long-Term Deferred Tax Liabilities | 27.04 | 30.88 | 26.88 | 28.7 | 28.61 | 34.97 |
Total Liabilities | 1,559 | 1,473 | 1,869 | 1,930 | 1,536 | 1,810 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 447.29 | 447.29 | 447.29 | 320.64 | 320.64 | 320.64 |
Additional Paid-In Capital | - | 0.81 | 0.45 | 10.09 | - | - |
Retained Earnings | 4,097 | 3,975 | 3,675 | 3,571 | 3,071 | 2,522 |
Treasury Stock | -99.51 | - | - | -100.99 | -99.99 | - |
Comprehensive Income & Other | -190.88 | -189.33 | -95.02 | 14.32 | 19.59 | 37.64 |
Total Common Equity | 4,254 | 4,234 | 4,028 | 3,815 | 3,311 | 2,881 |
Minority Interest | 436.46 | 335.14 | 331.29 | 317.48 | 307.48 | 263.8 |
Shareholders' Equity | 4,691 | 4,569 | 4,359 | 4,132 | 3,618 | 3,144 |
Total Liabilities & Equity | 6,249 | 6,042 | 6,228 | 6,062 | 5,154 | 4,955 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,235 | 1,112 | 1,445 | 1,459 | 1,154 | 1,299 |
Net Cash (Debt) | -614.81 | -413.56 | -822.56 | -864.77 | -523.63 | -455.02 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.38 | -0.92 | -1.84 | -1.94 | -1.17 | -1.01 |
Filing Date Shares Outstanding | 449.77 | 447.29 | 447.29 | 447.95 | 449.09 | 449.09 |
Total Common Shares Outstanding | 449.77 | 447.29 | 447.29 | 447.95 | 449.09 | 449.09 |
Working Capital | 223.25 | 335.21 | 324.49 | 278.38 | 634.43 | 396.14 |
Book Value Per Share | 9.46 | 9.47 | 9.00 | 8.52 | 7.37 | 6.41 |
Tangible Book Value | 4,010 | 3,987 | 3,875 | 3,706 | 3,248 | 2,818 |
Tangible Book Value Per Share | 8.91 | 8.91 | 8.66 | 8.27 | 7.23 | 6.27 |
Buildings | - | 908.07 | 799.43 | 799.43 | 795.97 | 829.35 |
Machinery | - | 720.38 | 673.9 | 632.72 | 577.32 | 501.77 |
Construction In Progress | - | 1,039 | 1,076 | 850.66 | 260.37 | 198.88 |